TemREN Peripheral Atherectomy System

What is TemREN Peripheral Atherectomy System?

말초 동맥의 플라크 제거에 특화된 회전식 또는 방향성 죽종절제술 장치로 압력상해를 최소화하면서 내강 복원을 강화합니다.

How does TemREN Peripheral Atherectomy System work?

최소 침습 중재를 위해 설계된 첨단 의료기기. 신뢰할 수 있는 성능과 최적의 임상 결과 제공.

What are the technical specifications?

TemREN Peripheral Atherectomy System - 1: Product Name: TemREN Peripheral Atherectomy System. Intended Use: Minimally invasive plaque excision in peripheral arteries (e.g., femoral, popliteal, tibial) for PAD management. Atherectomy Mechanism: Rotational or directional cutting tip with torque transfer shaft. Material: Stainless steel or nitinol shaft, specialized high-hardness cutting burr or blade. Rotational Speed Range: Typically 40,000–100,000 rpm (depends on burr size and specific model).

Who manufactures TemREN Peripheral Atherectomy System?

TemREN Peripheral Atherectomy System is manufactured by INVAMED, a globally recognized medical device company headquartered in Ankara, Turkey. INVAMED holds over 100 international patents and exports CE marked devices to more than 80 countries. The company is ISO 13485 certified and FDA registered through Standard Technology Solutions, Inc. at One World Trade Center, New York.

What category does TemREN Peripheral Atherectomy System belong to?

TemREN Peripheral Atherectomy System is part of the Peripheral Arterial Disease (PAD) product portfolio by INVAMED. This category includes advanced medical devices designed for interventional procedures performed by healthcare professionals worldwide.

Which medical specialties use TemREN Peripheral Atherectomy System?

TemREN Peripheral Atherectomy System is used by specialists in Arterial, Peripheral. These physicians rely on INVAMED devices for minimally invasive diagnostic and therapeutic procedures.

Is TemREN Peripheral Atherectomy System CE marked and FDA registered?

Yes. TemREN Peripheral Atherectomy System carries CE marking under EU MDR 2017/745 and is manufactured in ISO 13485 certified facilities. It is available in the U.S. market through FDA-registered Standard Technology Solutions, Inc.